We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+15.52%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$996M
AUM Growth
-$1.91B
Cap. Flow
-$2.11B
Cap. Flow %
-211.83%
Top 10 Hldgs %
20.58%
Holding
239
New
10
Increased
21
Reduced
180
Closed
28

Sector Composition

Rank Sector Weight
1 Technology 30.35%
2 Healthcare 21%
3 Industrials 11.06%
4 Financials 10.57%
5 Consumer Discretionary 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KWR icon
51
Quaker Houghton
KWR
$2.92B
$6.91M 0.69%
52,479
-153,899
-75% -$20.1M
EEFT icon
52
Euronet Worldwide
EEFT
$2.7B
$6.51M 0.65%
76,094
-438,194
-85% -$34.4M
TWLO icon
53
Twilio
TWLO
$36.6B
$6.5M 0.65%
225,144
-41,556
-16% -$1.26M
CNMD icon
54
CONMED
CNMD
$1.47B
$6.27M 0.63%
141,279
-340,146
-71% -$14.6M
TCBI icon
55
Texas Capital Bancshares
TCBI
$4.32B
$6.21M 0.62%
74,400
-311,025
-81% -$26.1M
BWLD
56
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$6.15M 0.62%
40,254
-19,352
-32% -$2.95M
PRO
57
DELISTED
PROS Holdings
PRO
$6.12M 0.61%
252,981
-625,703
-71% -$14.1M
ENTA icon
58
Enanta Pharmaceuticals
ENTA
$400M
$6.08M 0.61%
197,408
-298,617
-60% -$9.3M
PCRX icon
59
Pacira BioSciences
PCRX
$997M
$6.05M 0.61%
132,665
-503,815
-79% -$21.8M
PAYC icon
60
Paycom
PAYC
$9.69B
$6.01M 0.6%
104,546
-219,176
-68% -$11.4M
SUPN icon
61
Supernus Pharmaceuticals
SUPN
$2.77B
$5.98M 0.6%
190,938
-520,661
-73% -$14M
IRWD icon
62
Ironwood Pharmaceuticals
IRWD
$714M
$5.97M 0.6%
418,028
-1,263,124
-75% -$17.3M
TRVG
63
trivago
TRVG
$397M
$5.97M 0.6%
91,653
+59,813
+188% +$3.62M
PRFT
64
DELISTED
Perficient Inc
PRFT
$5.79M 0.58%
333,667
-710,943
-68% -$12.7M
CVGW
65
DELISTED
Calavo Growers
CVGW
$5.48M 0.55%
90,370
-22,960
-20% -$1.32M
HIVE
66
DELISTED
Aerohive Networks
HIVE
$5.39M 0.54%
1,279,645
-627,089
-33% -$3.15M
SGMO
67
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$5.37M 0.54%
1,032,859
+794,508
+333% +$3.19M
POWI icon
68
Power Integrations
POWI
$3.61B
$5.29M 0.53%
160,982
-382,182
-70% -$12.7M
SMCI icon
69
Super Micro Computer
SMCI
$20.1B
$5.26M 0.53%
2,073,870
-6,378,890
-75% -$16.9M
INST
70
DELISTED
Instructure, Inc.
INST
$4.98M 0.5%
212,717
+35,807
+20% +$813K
XLRN
71
DELISTED
Acceleron Pharma
XLRN
$4.95M 0.5%
187,092
-493,117
-72% -$13M
PCTY icon
72
Paylocity
PCTY
$7.98B
$4.94M 0.5%
+127,782
New +$4.44M
PRTK
73
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4.87M 0.49%
253,200
-202,030
-44% -$3.18M
DXCM icon
74
DexCom
DXCM
$32B
$4.87M 0.49%
229,808
-1,095,792
-83% -$21.4M
CASH icon
75
Pathward Financial
CASH
$1.8B
$4.75M 0.48%
161,172
-82,338
-34% -$2.55M

Similar funds

Granahan Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Granahan Investment Management held 239 positions worth $996M, down 66% from $2.91B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Granahan Investment Management withdrew a net $2.11B in Q1 2017, closing 28 positions and reducing 180 holdings. Its most notable exit was Cynosure, Inc. Class A, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Granahan Investment Management opened a new position in Paylocity worth $4.94M.

  • Granahan Investment Management's largest Q1 2017 buy was Paylocity: 127,782 shares worth $4.94M.
  • Granahan Investment Management added most to Kornit Digital in Q1 2017, an estimated $10.6M increase.
  • Granahan Investment Management's biggest Q1 2017 reduction was Abiomed Inc, cutting an estimated $52.4M.
  • Granahan Investment Management fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $31.8M.
  • Granahan Investment Management's ten largest holdings make up 21% of its $996M portfolio in Q1 2017.
  • Granahan Investment Management opened 10 new positions and closed 28 in Q1 2017.
  • Granahan Investment Management's portfolio value fell 66% quarter-over-quarter to $996M.

Based on Granahan Investment Management's 13F filing for Q1 2017, filed 15 May 2017.